Skip to main content
. 2009 Jun 10;297(2):F282–F291. doi: 10.1152/ajprenal.90742.2008

Table 2.

Serum parameters in control-1 and FGFR1−/− mice post-FGF23 administration

Control-1
FGFR1−/−
Vehicle FGF23 Vehicle FGF23
Serum phosphorus, mg/dl (pre- vs. post-FGF23 5.9±0.4 vs. 6.6±0.3 (n=11) 5.8±0.3 vs. 4.2±0.4*(n=11) 6.2±0.5 vs. 6.9±0.5 (n=8) 5.6±0.3 vs. 5.2±0.5 (n=10)
Serum FGF23, pg/ml 137.8±3.4 (n=6) 809.7±75.2 (n=6) 247.0±32.7§ (n=8) 941.1±184.3 (n=10)
Serum 1,25(OH)2D3, pmol/l 87.5±18.7 (n=8) 11.8±0.7 (n=10) 86.8±20.1 (n=6) 11.3±0.8 (n=7)
Serum PTH, pg/ml 122.8±16.4 (n=13) 107.8±27.4 (n=10) 209.4±42.1§ (n=10) 130.8±15.8 (n=8)

Values are means ± SE; n = no. of mice.

*

P < 0.05, pre vs. post-FGF23.

P ≤ 0.005, vehicle vs. FGF23.

P ≤ 0.001, vehicle vs. FGF23.

§

P=0.05, control-1 vehicle vs. FGFR1−/− vehicle.